shortagewatch

Home / Omeprazole / Italy

IT ATC A02BC01 · updated 2 Nov 2026

Omeprazole shortage in Italy

Is there an Omeprazole shortage in Italy?

Yes. As of 2 Nov 2026, 13 Omeprazole products are reported short in Italy, the first since 31 Jan 2023. No return date has been given. Main reason: commercial decision or withdrawal.

Also short in Canada, Spain, Czechia, Norway, Sweden, Japan, New Zealand. All countries.

Affected products in Italy

CountryProductCompanySinceExpected backReason
ITOMEPRAZOLO SUNSUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.31 Jan 2023not givenManufacturing problem
Problemi produttivi
ITOMEPRAZOLO ZENTIVA SRL discontinuationZENTIVA ITALIA S.R.L.31 Oct 2023not givenIncreased demand
Elevata richiesta
ITOMEPRAZOLO ZENTIVA ITALIAZENTIVA ITALIA S.R.L.1 Apr 2024not givenManufacturing problem
Problemi produttivi
ITOMEPRAZOLO ALMUS PHARMAPHARMACARE S.R.L.1 Aug 2024not givenCommercial decision or withdrawal
Motivi commerciali
ITOMASEPTPHARMACARE S.R.L.1 Feb 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ITOMASEPTPHARMACARE S.R.L.1 Apr 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ITOMEPRAZOLO PHARMACAREPHARMACARE S.R.L.1 Jul 2025not givenCommercial decision or withdrawal
Motivi commerciali
ITOMEPRAZOLO P-CAREPHARMACARE S.R.L.27 Oct 2025not givenCommercial decision or withdrawal
Motivi commerciali
ITOMEPRAZOLO P-CAREPHARMACARE S.R.L.30 Nov 2025not givenCommercial decision or withdrawal
Motivi commerciali
ITGASTROSCHOUM REFLUSSOZENTIVA ITALIA S.R.L.5 Jun 2026not givenManufacturing problem
Problemi produttivi
ITOMEPRAZOLO ZENTIVA ITALIAZENTIVA ITALIA S.R.L.30 Jun 2026not givenManufacturing problem
Problemi produttivi
ITOMEPRAZOLO AZEVEDOS anticipatedSO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI28 Dec 2026not givenCommercial decision or withdrawal
Motivi commerciali
ITOMEPRAZOLO PHARMACARE anticipatedPHARMACARE S.R.L.1 Jul 2027not givenCommercial decision or withdrawal
Motivi commerciali

Source

AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.